Related references
Note: Only part of the references are listed.Liver-resident NK cells suppress autoimmune cholangitis and limit the proliferation of CD4+ T cells
Zhi-Bin Zhao et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Adding Indoximod to Hypofractionated Radiotherapy with Anti-PD-1 Checkpoint Blockade Enhances Early NK and CD8+ T-Cell-Dependent Tumor Activity
Tsubasa Watanabe et al.
CLINICAL CANCER RESEARCH (2020)
Prognostic value of peripheral blood natural killer cells in colorectal cancer
Yan-ping Tang et al.
BMC GASTROENTEROLOGY (2020)
Monocarboxylate transporter 1 blockade with AZD3965 inhibits lipid biosynthesis and increases tumour immune cell infiltration
Mounia Beloueche-Babari et al.
BRITISH JOURNAL OF CANCER (2020)
Tissue Determinants of Human NK Cell Development, Function, and Residence
Pranay Dogra et al.
CELL (2020)
High Serum Levels of Cholesterol Increase Anti-tumor Functions of Nature Killer Cells and Reduce Growth of Liver Tumors in Mice
Wen-Hao Qin et al.
GASTROENTEROLOGY (2020)
CD73 immune checkpoint defines regulatory NK cells within the tumor microenvironment
Shi Yong Neo et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
Enli Liu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Tumor heterogeneity and clonal cooperation influence the immune selection of IFN-γ-signaling mutant cancer cells
Jason B. Williams et al.
NATURE COMMUNICATIONS (2020)
Glycolysis and Oxidative Phosphorylation Play Critical Roles in Natural Killer Cell Receptor-Mediated Natural Killer Cell Functions
Zixi Wang et al.
FRONTIERS IN IMMUNOLOGY (2020)
Glycoengineering of Natural Killer Cells with CD22 Ligands for Enhanced Anticancer Immunotherapy
Xianwu Wang et al.
ACS CENTRAL SCIENCE (2020)
Combination of monalizumab and cetuximab in recurrent or metastatic head and neck cancer patients previously treated with platinum-based chemotherapy and PD-(L)1 inhibitors.
Roger B. Cohen et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Harnessing Natural Killer Immunity in Metastatic SCLC
Sarah A. Best et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-gamma, CXCL9 and CXCL10
Cristina Bergamaschi et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Phase I study of intraventricular infusions of autologous ex vivo expanded NK cells in children with recurrent medulloblastoma and ependymoma
Soumen Khatua et al.
NEURO-ONCOLOGY (2020)
IL15 Stimulation with TIGIT Blockade Reverses CD155-mediated NK-Cell Dysfunction in Melanoma
Joe-Marc Chauvin et al.
CLINICAL CANCER RESEARCH (2020)
Phase I Trial of Expanded, Activated Autologous NK-cell Infusions with Trastuzumab in Patients with HER2-positive Cancers
Soo-Chin Lee et al.
CLINICAL CANCER RESEARCH (2020)
CD38 deletion of human primary NK cells eliminates daratumumab-induced fratricide and boosts their effector activity
Meisam Naeimi Kararoudi et al.
BLOOD (2020)
Metabolic Reprograming via Deletion of CISH in Human iPSC-Derived NK Cells Promotes In Vivo Persistence and Enhances Anti-tumor Activity
Huang Zhu et al.
CELL STEM CELL (2020)
Antibody targeting tumor-derived soluble NKG2D ligand sMIC reprograms NK cell homeostatic survival and function and enhances melanoma response to PDL1 blockade therapy
Fahmin Basher et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Low absolute NK cell counts in peripheral blood are associated with inferior survival in patients with mantle cell lymphoma
Xiao-Hui Zhou et al.
CANCER BIOMARKERS (2019)
Natural killer group 2D receptor and its ligands in cancer immune escape
Shixin Duan et al.
MOLECULAR CANCER (2019)
Immunometabolism regulates TCR recycling and iNKT cell functions
Sicheng Fu et al.
SCIENCE SIGNALING (2019)
Cancer-associated fibroblasts enhance tumor-associated macrophages enrichment and suppress NK cells function in colorectal cancer
Rongsheng Zhang et al.
CELL DEATH & DISEASE (2019)
IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion
Kevin C. Conlon et al.
CLINICAL CANCER RESEARCH (2019)
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells
Takahiro Kamiya et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
A First-in-Human Study and Biomarker Analysis of NKTR-214, a Novel 1L2Rβγ-Biased Cytokine, in Patients with Advanced or Metastatic Solid Tumors
Salah-Eddine Bentebibel et al.
CANCER DISCOVERY (2019)
CD33 (Siglec-3) Inhibitory Function: Role in the NKG2D/DAP10 Activating Pathway
Trinidad Hernandez-Caselles et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2019)
The Tumor Microenvironment Innately Modulates Cancer Progression
Dominique C. Hinshaw et al.
CANCER RESEARCH (2019)
Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion
Anna M. Paczulla et al.
NATURE (2019)
The macrophage tetraspan MS4A4A enhances dectin-1-dependent NK cell-mediated resistance to metastasis
Irene Mattiola et al.
NATURE IMMUNOLOGY (2019)
NK cell-intrinsic FcεRIγ limits CD8+ T-cell expansion and thereby turns an acute into a chronic viral infection
Vikas Duhan et al.
PLOS PATHOGENS (2019)
Accumulation of Tumor-Infiltrating CD49a+ NK Cells Correlates with Poor Prognosis for Human Hepatocellular Carcinoma
Haoyu Sun et al.
CANCER IMMUNOLOGY RESEARCH (2019)
The Natural Cytotoxicity Receptors in Health and Disease
Alexander David Barrow et al.
FRONTIERS IN IMMUNOLOGY (2019)
NK Cells in the Human Lungs
Baptiste Hervier et al.
FRONTIERS IN IMMUNOLOGY (2019)
Human natural killer cells mediate adaptive immunity to viral antigens
Rana Nikzad et al.
SCIENCE IMMUNOLOGY (2019)
Lipid accumulation impairs natural killer cell cytotoxicity and tumor control in the postoperative period
Seyedeh Raheleh Niavarani et al.
BMC CANCER (2019)
Triple Therapy with MerTK and PD1 Inhibition Plus Radiotherapy Promotes Abscopal Antitumor Immune Responses
Mauricio S. Caetano et al.
CLINICAL CANCER RESEARCH (2019)
Killers 2.0: NK cell therapies at the forefront of cancer control
Jonathan J. Hodgins et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Natural Killer Cells Suppress T Cell-Associated Tumor Immune Evasion
Andrew J. Freeman et al.
CELL REPORTS (2019)
Gab3 is required for IL-2-and IL-15-induced NK cell expansion and limits trophoblast invasion during pregnancy
Anna Sliz et al.
SCIENCE IMMUNOLOGY (2019)
Mitochondrial fragmentation limits NK cell-based tumor immunosurveillance
Xiaohu Zheng et al.
NATURE IMMUNOLOGY (2019)
Heterogeneity of human bone marrow and blood natural killer cells defined by single-cell transcriptome
Chao Yang et al.
NATURE COMMUNICATIONS (2019)
Distinct CD1d docking strategies exhibited by diverse Type II NKT cell receptors
Catarina F. Almeida et al.
NATURE COMMUNICATIONS (2019)
Synergized regulation of NK cell education by NKG2A and specific Ly49 family members
Xiaoqian Zhang et al.
NATURE COMMUNICATIONS (2019)
Hypoxia Regulates Lymphoid Development of Human Hematopoietic Progenitors
Sara Chabi et al.
CELL REPORTS (2019)
NK cells suppress CD8+ T cell immunity via NKG2D in severe aplastic anemia
Tong Chen et al.
CELLULAR IMMUNOLOGY (2019)
Human CD96 Correlates to Natural Killer Cell Exhaustion and Predicts the Prognosis of Human Hepatocellular Carcinoma
Haoyu Sun et al.
HEPATOLOGY (2019)
Circulating NKp46+ Natural Killer cells have a potential regulatory property and predict distinct survival in Non-Small Cell Lung Cancer
Emilie Picard et al.
ONCOIMMUNOLOGY (2019)
Adult peripheral blood and umbilical cord blood NK cells are good sources for effective CAR therapy against CD19 positive leukemic cells
L. Herrera et al.
SCIENTIFIC REPORTS (2019)
Lymphocyte-activation gene 3 (LAG3): The next immune checkpoint receptor
Elisa Ruffo et al.
SEMINARS IN IMMUNOLOGY (2019)
Mitochondrial hypoxic stress induces widespread RNA editing by APOBEC3G in natural killer cells
Shraddha Sharma et al.
GENOME BIOLOGY (2019)
NK Cell Infiltrates and HLA Class I Expression in Primary HER2+ Breast Cancer Predict and Uncouple Pathological Response and Disease-free Survival
Aura Muntasell et al.
CLINICAL CANCER RESEARCH (2019)
Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity
E. Liu et al.
LEUKEMIA (2018)
Impact of Th1/Th2 cytokine polarity induced by invariant NKT cells on the incidence of pregnancy loss in mice
Mari Hoya et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2018)
Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL
Frank Vari et al.
BLOOD (2018)
First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation
Rizwan Romee et al.
BLOOD (2018)
An Integrated View of Immunometabolism
Yun Sok Lee et al.
CELL (2018)
NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control
Jan P. Boettcher et al.
CELL (2018)
Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity
Ye Li et al.
CELL STEM CELL (2018)
Aberrant Lck Signal via CD28 Costimulation Augments Antigen-Specific Functionality and Tumor Control by Redirected T Cells with PD-1 Blockade in Humanized Mice
Pratiksha Gulati et al.
CLINICAL CANCER RESEARCH (2018)
Next generation natural killer cells for cancer immunotherapy: the promise of genetic engineering
May Daher et al.
CURRENT OPINION IN IMMUNOLOGY (2018)
Innate Lymphoid Cell Development: A T Cell Perspective
Dylan E. Cherrier et al.
IMMUNITY (2018)
Elevated absolute NK cell counts in peripheral blood predict good prognosis in chronic lymphocytic leukemia
Wen-Ting Wang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
Randomized Phase II Trial of Fulvestrant Plus Everolimus or Placebo in Postmenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy: Results of PrE0102
Noah Kornblum et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial
John M. Wrangle et al.
LANCET ONCOLOGY (2018)
The GM2 ganglioside inhibits iNKT cell responses in a CD1d-dependent manner
C. S. Pereira et al.
MOLECULAR GENETICS AND METABOLISM (2018)
TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis
Daniele V. F. Tauriello et al.
NATURE (2018)
Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity
Qing Zhang et al.
NATURE IMMUNOLOGY (2018)
Natural killer cell specificity for viral infections
Quirin Hammer et al.
NATURE IMMUNOLOGY (2018)
Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells
Margherita Norelli et al.
NATURE MEDICINE (2018)
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
S. L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Amino acid-dependent cMyc expression is essential for NK cell metabolic and functional responses in mice
Roisin M. Loftus et al.
NATURE COMMUNICATIONS (2018)
CD96 targeted antibodies need not block CD96-CD155 interactions to promote NK cell anti-metastatic activity
Amelia Roman Aguilera et al.
ONCOIMMUNOLOGY (2018)
Everolimus Plus Exemestane vs Everolimus or Capecitabine Monotherapy for Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer The BOLERO-6 Randomized Clinical Trial
Guy Jerusalem et al.
JAMA ONCOLOGY (2018)
Anergic natural killer cells educated by tumor cells are associated with a poor prognosis in patients with advanced pancreatic ductal adenocarcinoma
Chao Yang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Actin Cytoskeleton Remodeling Drives Breast Cancer Cell Escape from Natural Killer-Mediated Cytotoxicity
Antoun Al Absi et al.
CANCER RESEARCH (2018)
Natural killer cells induce distinct modes of cancer cell death: Discrimination, quantification, and modulation of apoptosis, necrosis, and mixed forms
Christian S. Backes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
First-in-human dose escalation of monalizumab plus durvalumab, with expansion in patients with metastatic microsatellite-stable colorectal cancer.
Neil Howard Segal et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Sanjeev Mariathasan et al.
NATURE (2018)
The Number of Natural Killer Cells in the Largest Diameter Lymph Nodes Is Associated with the Number of Retrieved Lymph Nodes and Lymph Node Size, and Is an Independent Prognostic Factor in Patients with Stage II Colon Cancer
Kazutake Okada et al.
ONCOLOGY (2018)
Tissue-resident NK cells differ in their expression profile of the nutrient transporters Glut1, CD98 and CD71
Wilhelm Salzberger et al.
PLOS ONE (2018)
Prostaglandin E2 Secreted by Thyroid Cancer Cells Contributes to Immune Escape Through the Suppression of Natural Killer (NK) Cell Cytotoxicity and NK Cell Differentiation
Arum Park et al.
FRONTIERS IN IMMUNOLOGY (2018)
High-Dimensional Single-Cell Analysis Identifies Organ-Specific Signatures and Conserved NK Cell Subsets in Humans and Mice
Adeline Crinier et al.
IMMUNITY (2018)
Metabolic reprogramming of natural killer cells in obesity limits antitumor responses
Xavier Michelet et al.
NATURE IMMUNOLOGY (2018)
Infection, modulation and responses of antigen-presenting cells to African swine fever viruses
Giulia Franzoni et al.
VIRUS RESEARCH (2018)
Recognition of host Clr-b by the inhibitory NKR-P1B receptor provides a basis for missing-self recognition
Gautham R. Balaji et al.
NATURE COMMUNICATIONS (2018)
Intratumoral CD56bright natural killer cells are associated with improved survival in bladder cancer
Neelam Mukherjee et al.
Oncotarget (2018)
PD-L1 Mediates Dysfunction in Activated PD-1(+) NK Cells in Head and Neck Cancer Patients
Fernando Concha-Benavente et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Natural killer cells and other innate lymphoid cells in cancer
Laura Chiossone et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Tissue-specific functions of invariant natural killer T cells
Catherine M. Crosby et al.
NATURE REVIEWS IMMUNOLOGY (2018)
A2AR Adenosine Signaling Suppresses Natural Killer Cell Maturation in the Tumor Microenvironment
Arabella Young et al.
CANCER RESEARCH (2018)
Prognostic impact of the expression of NCR1 and NCR3 NK cell receptors and PD-L1 on advanced non-small cell lung cancer
Laetitia Fend et al.
ONCOIMMUNOLOGY (2017)
Natural killer-cell counts are associated with molecular relapse-free survival after imatinib discontinuation in chronic myeloid leukemia: the IMMUNOSTIM study
Delphine Rea et al.
HAEMATOLOGICA (2017)
Adipose Type One Innate Lymphoid Cells Regulate Macrophage Homeostasis through Targeted Cytotoxicity
Selma Boulenouar et al.
IMMUNITY (2017)
Human Innate Lymphoid Cell Subsets Possess Tissue-Type Based Heterogeneity in Phenotype and Frequency
Yannick Simoni et al.
IMMUNITY (2017)
Human lung natural killer cells are predominantly comprised of highly differentiated hypofunctional CD69-CD56dim cells
Nicole Marquardt et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
CD56bright NK cells exhibit potent antitumor responses following IL-15 priming
Julia A. Wagner et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade
Mark Ayers et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
KIR3DL1/HLA-B Subtypes Govern Acute Myelogenous Leukemia Relapse After Hematopoietic Cell Transplantation
Jeanette E. Boudreau et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
A distinct innate lymphoid cell population regulates tumor-associated T cells
Sarah Q. Crome et al.
NATURE MEDICINE (2017)
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
S. S. Neelapu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers
Y. Liu et al.
ONCOGENE (2017)
Natural killer cells unleashed: Checkpoint receptor blockade and BiKE/TriKE utilization in NK-mediated anti-tumor immunotherapy
Zachary B. Davis et al.
SEMINARS IN IMMUNOLOGY (2017)
IL-21-mediated reversal of NK cell exhaustion facilitates anti-tumour immunity in MHC class I-deficient tumours
Hyungseok Seo et al.
NATURE COMMUNICATIONS (2017)
The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells
Amy E. Baek et al.
NATURE COMMUNICATIONS (2017)
Peripheral human CD4+CD8+ T lymphocytes exhibit a memory phenotype and enhanced responses to IL-2, IL-7 and IL-15
Marie-Laure Clenet et al.
SCIENTIFIC REPORTS (2017)
Natural killer-cell counts are associated with molecular relapse-free survival after imatinib discontinuation in chronic myeloid leukemia: the IMMUNOSTIM study
Delphine Rea et al.
HAEMATOLOGICA (2017)
RIG-I Resists Hypoxia-Induced Immunosuppression and Dedifferentiation
Christina Engel et al.
CANCER IMMUNOLOGY RESEARCH (2017)
MICA-Expressing Monocytes Enhance Natural Killer Cell Fc Receptor-Mediated Antitumor Functions
Amanda R. Campbell et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Tumor-Associated Monocytes/Macrophages Impair NK-Cell Function via TGFβ1 in Human Gastric Cancer
Liu-sheng Peng et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Human CD56dimCD16dim Cells As an Individualized Natural Killer Cell Subset
Mathieu Amand et al.
FRONTIERS IN IMMUNOLOGY (2017)
Uterine Natural Killer Cells: Functional Distinctions and influence on Pregnancy in Humans and Mice
Louise M. Gaynor et al.
FRONTIERS IN IMMUNOLOGY (2017)
Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment
Susanne M. Steggerda et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Glycolytic requirement for NK cell cytotoxicity and cytomegalovirus control
Annelise Y. Mah et al.
JCI INSIGHT (2017)
Cellular kinetics of CTL019 in relapsed/refractory B-cell acute lymphoblastic leukemia and chronic lymphocytic leukemia
Karen Thudium Mueller et al.
BLOOD (2017)
Srebp-controlled glucose metabolism is essential for NK cell functional responses
Nadine Assmann et al.
NATURE IMMUNOLOGY (2017)
Blockade of CD112R and TIGIT signaling sensitizes human natural killer cell functions
Feng Xu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
KIR, LILRB and their Ligands' Genes as Potential Biomarkers in Recurrent Implantation Failure
Izabela Nowak et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2017)
Successful Transfer of Umbilical Cord Blood CD34+ Hematopoietic Stem and Progenitor-derived NK Cells in Older Acute Myeloid Leukemia Patients
Harry Dolstra et al.
CLINICAL CANCER RESEARCH (2017)
IL-6/Stat3-Dependent Induction of a Distinct, Obesity-Associated NK Cell Subpopulation Deteriorates Energy and Glucose Homeostasis
Sebastian Theurich et al.
CELL METABOLISM (2017)
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses
Yonit Lavin et al.
CELL (2017)
Complement factor P is a ligand for the natural killer cell-activating receptor NKp46
Emilie Narni-Mancinelli et al.
SCIENCE IMMUNOLOGY (2017)
Emerging Biological Principles of Metastasis
Arthur W. Lambert et al.
CELL (2017)
Heparan sulfate mimetic PG545-mediated antilymphoma effects require TLR9-dependent NK cell activation
Todd V. Brennan et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
IL-21 Is Important for Induction of KLRG1+ Effector CD8 T Cells during Acute Intracellular Infection
Magali M. Moretto et al.
JOURNAL OF IMMUNOLOGY (2016)
Toxicities of chimeric antigen receptor T cells: recognition and management
Jennifer N. Brudno et al.
BLOOD (2016)
Enhancement of tumor cell susceptibility to natural killer cell activity through inhibition of the PI3K signaling pathway
Davide Bommarito et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Adaptive NK Cells with Low TIGIT Expression Are Inherently Resistant to Myeloid-Derived Suppressor Cells
Dhifaf Sarhan et al.
CANCER RESEARCH (2016)
NKT cell subsets as key participants in liver physiology and pathology
Keya Bandyopadhyay et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2016)
Checkpoint Inhibition of KIR2D with the Monoclonal Antibody IPH2101 Induces Contraction and Hyporesponsiveness of NK Cells in Patients with Myeloma
Mattias Carlsten et al.
CLINICAL CANCER RESEARCH (2016)
Phenotype and functions of conventional and non-conventional NK cells
Timothy K. Erick et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
Adipose-Resident Group 1 Innate Lymphoid Cells Promote Obesity-Associated Insulin Resistance
Timothy E. O'Sullivan et al.
IMMUNITY (2016)
Bioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8+ T Cell Exhaustion
Bertram Bengsch et al.
IMMUNITY (2016)
Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors
Jonathan M. Pitt et al.
IMMUNITY (2016)
Cancer-associated fibroblast suppresses killing activity of natural killer cells through downregulation of poliovirus receptor (PVR/CD155), a ligand of activating NK receptor
Tomoko Inoue et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
CD19-CAR engineered NK-92 cells are sufficient to overcome NK cell resistance in B-cell malignancies
Annette Romanski et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2016)
CD1d-restricted peripheral T cell lymphoma in mice and humans
Emmanuel Bachy et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
CD8αα+MHC Class II+ Cell with the Capacity To Terminate Autoimmune Inflammation Is a Novel Antigen-Presenting NK-like Cell in Rats
Jean Wu et al.
JOURNAL OF IMMUNOLOGY (2016)
Metabolic Reprogramming Supports IFN-γ Production by CD56bright NK Cells
Sinead E. Keating et al.
JOURNAL OF IMMUNOLOGY (2016)
CIS is a potent checkpoint in NK cell-mediated tumor immunity
Rebecca B. Delconte et al.
NATURE IMMUNOLOGY (2016)
Targeting natural killer cells in cancer immunotherapy
Camille Guillerey et al.
NATURE IMMUNOLOGY (2016)
Trained immunity: A program of innate immune memory in health and disease
Mihai G. Netea et al.
SCIENCE (2016)
TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway
Sebastien Viel et al.
SCIENCE SIGNALING (2016)
Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia
Rizwan Romee et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Suppression of Metastases Using a New Lymphocyte Checkpoint Target for Cancer Immunotherapy
Stephen J. Blake et al.
CANCER DISCOVERY (2016)
NK cell count and glucotransporter 4 (GLUT4) expression in subjects with type 2 diabetes and colon cancer
Pawel Piatkiewicz et al.
DIABETOLOGY & METABOLIC SYNDROME (2016)
NKp80 Defines a Critical Step during Human Natural Killer Cell Development
Aharon G. Freud et al.
CELL REPORTS (2016)
TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway
Sebastien Viel et al.
SCIENCE SIGNALING (2016)
The proto-oncogene Myc drives expression of the NK cell-activating NKp30 ligand B7-H6 in tumor cells
Sonja Textor et al.
ONCOIMMUNOLOGY (2016)
Highly efficient IL-21 and feeder cell-driven ex vivo expansion of human NK cells with therapeutic activity in a xenograft mouse model of melanoma
Markus Granzin et al.
ONCOIMMUNOLOGY (2016)
Natural killer cell memory in infection, inflammation and cancer
Adelheid Cerwenka et al.
NATURE REVIEWS IMMUNOLOGY (2016)
CD16-IL15-CD33 Trispecific Killer Engager (TriKE) Overcomes Cancer-Induced Immune Suppression and Induces Natural Killer Cell-Mediated Control of MDS and AML Via Enhanced Killing Kinetics
Martin Felices et al.
BLOOD (2016)
IL-7-Induced Glycerol Transport and TAG Synthesis Promotes Memory CD8+ T Cell Longevity
Guoliang Cui et al.
CELL (2015)
A Phase I Trial of the Anti-KIR Antibody IPH2101 and Lenalidomide in Patients with Relapsed/Refractory Multiple Myeloma
Don M. Benson et al.
CLINICAL CANCER RESEARCH (2015)
TIGIT expression levels on human NK cells correlate with functional heterogeneity among healthy individuals
Feng Wang et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
IL-12/15/18-preactivated NKcells suppress GvHD in a mouse model of mismatched hematopoietic cell transplantation
Christian M. Hueber et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer
Kevin C. Conlon et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Activation-Specific Metabolic Requirements for NK Cell IFN-γ Production
Molly P. Keppel et al.
JOURNAL OF IMMUNOLOGY (2015)
Cutting Edge: Identification and Characterization of Human Intrahepatic CD49a+ NK Cells
Nicole Marquardt et al.
JOURNAL OF IMMUNOLOGY (2015)
Natural killer (NK) cell profiles in blood and tumour in women with large and locally advanced breast cancer (LLABC) and their contribution to a pathological complete response (PCR) in the tumour following neoadjuvant chemotherapy (NAC): differential restoration of blood profiles by NAC and surgery
Chandan Verma et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Sulforaphane induces ROS mediated induction of NKG2D ligands in human cancer cell lines and enhances susceptibility to NK cell mediated lysis
Prayag J. Amin et al.
LIFE SCIENCES (2015)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection
Weiwen Deng et al.
SCIENCE (2015)
Radiotherapy and Immunogenic Cell Death
Encouse B. Golden et al.
SEMINARS IN RADIATION ONCOLOGY (2015)
Natural cytotoxicity receptor splice variants orchestrate the distinct functions of human natural killer cell subtypes
Johan Siewiera et al.
NATURE COMMUNICATIONS (2015)
Defined TLR3-specific adjuvant that induces NK and CTL activation without significant cytokine production in vivo
Misako Matsumoto et al.
NATURE COMMUNICATIONS (2015)
Highly effective NK cells are associated with good prognosis in patients with metastatic prostate cancer
Christine Pasero et al.
ONCOTARGET (2015)
Is the Tumor Infiltrating Natural Killer Cell (NK-TILs) Count in Infiltrating Ductal Carcinoma of Breast Prognostically Significant?
Ankita Singh Rathore et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Preactivation with IL-12, IL-15, and IL-18 Induces CD25 and a Functional High-Affinity IL-2 Receptor on Human Cytokine-Induced Memory-like Natural Killer Cells
Jeffrey W. Leong et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Integrin receptors on tumor cells facilitate NK cell-mediated antibody-dependent cytotoxicity
Nadia Anikeeva et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
NK cells gain higher IFN-γ competence during terminal differentiation
Merlin Luetke-Eversloh et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
Natural cytotoxicity receptors and their ligands
Philip H. Kruse et al.
IMMUNOLOGY AND CELL BIOLOGY (2014)
The unconventional expression of IL-15 and its role in NK cell homeostasis
Nicholas D. Huntington
IMMUNOLOGY AND CELL BIOLOGY (2014)
Interplay between the immune system and adipose tissue in obesity
Mark A. Exley et al.
JOURNAL OF ENDOCRINOLOGY (2014)
Cytomegalovirus generates long-lived antigen-specific NK cells with diminished bystander activation to heterologous infection
Gundula Min-Oo et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
Matthew M. Gubin et al.
NATURE (2014)
The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions
Christopher J. Chan et al.
NATURE IMMUNOLOGY (2014)
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Shannon L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
NK Cell Phenotypic Modulation in Lung Cancer Environment
Shi Jin et al.
PLOS ONE (2014)
Innate immunodeficiency following genetic ablation of Mcl1 in natural killer cells
Priyanka Sathe et al.
NATURE COMMUNICATIONS (2014)
Expression of the Activating Receptor, NKp46 (CD335), in Human Natural Killer and T-Cell Neoplasia
Aharon G. Freud et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2013)
Hypoxia downregulates the expression of activating receptors involved in NK-cell-mediated target cell killing without affecting ADCC
Mirna Balsamo et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Monocyte/macrophage-elicited natural killer cell dysfunction in hepatocellular carcinoma is mediated by CD48/2B4 interactions
Yan Wu et al.
HEPATOLOGY (2013)
Intraepithelial Type 1 Innate Lymphoid Cells Are a Unique Subset of IL-12-and IL-15-Responsive IFN-γ-Producing Cells
Anja Fuchs et al.
IMMUNITY (2013)
Low NK cell counts in peripheral blood are associated with inferior overall survival in patients with follicular lymphoma
Danielle Shafer et al.
LEUKEMIA RESEARCH (2013)
Correction: HIV-1 Gp120 Protein Downregulates Nef Induced IL-6 Release in Immature Dentritic Cells through Interplay of DC-SIGN
Roni Sarkar et al.
PLoS One (2013)
Murine natural killer cell licensing and regulation by T regulatory cells in viral responses
Can M. Sungur et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Granzyme B degradation by autophagy decreases tumor cell susceptibility to natural killer-mediated lysis under hypoxia
Joanna Baginska et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
27-Hydroxycholesterol Links Hypercholesterolemia and Breast Cancer Pathophysiology
Erik R. Nelson et al.
SCIENCE (2013)
27-Hydroxycholesterol Promotes Cell-Autonomous, ER-Positive Breast Cancer Growth
Qian Wu et al.
CELL REPORTS (2013)
Human plasmacytoid dendritic cells are equipped with antigen-presenting and tumoricidal capacities
Jurjen Tel et al.
BLOOD (2012)
Cytokine activation induces human memory-like NK cells
Rizwan Romee et al.
BLOOD (2012)
Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO
Tuanjie Li et al.
CANCER LETTERS (2012)
Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicity
Jennifer T. Grier et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors
Jing Ni et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
HLA-C-Dependent Prevention of Leukemia Relapse by Donor Activating KIR2DS1
Jeffrey M. Venstrom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Targeting natural killer cells and natural killer T cells in cancer
Eric Vivier et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Impact of β2 integrin deficiency on mouse natural killer cell development and function
Karine Crozat et al.
BLOOD (2011)
Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients
Antonio Curti et al.
BLOOD (2011)
CX3CR1 expression defines 2 KLRG1+ mouse NK-cell subsets with distinct functional properties and positioning in the bone marrow
Giuseppe Sciume et al.
BLOOD (2011)
Human Breast Tumor Cells Induce Self-Tolerance Mechanisms to Avoid NKG2D-Mediated and DNAM-Mediated NK Cell Recognition
Emilie Mamessier et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer
Melissa A. Geller et al.
CYTOTHERAPY (2011)
Molecular Basis for LLT1 Protein Recognition by Human CD161 Protein (NKRP1A/KLRB1)
Jun Kamishikiryo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection
Manfred Brigl et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Homeostatic proliferation generates long-lived natural killer cells that respond against viral infection
Joseph C. Sun et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Innate or Adaptive Immunity? The Example of Natural Killer Cells
Eric Vivier et al.
SCIENCE (2011)
Presumed guilty: natural killer T cell defects and human disease
Stuart P. Berzins et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Education of human natural killer cells by activating killer cell immunoglobulin-like receptors
Cyril Fauriat et al.
BLOOD (2010)
Tumor Antigen-Targeted, Monoclonal Antibody-Based Immunotherapy: Clinical Response, Cellular Immunity, and Immunoescape
Robert L. Ferris et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
DNAM-1/CD155 Interactions Promote Cytokine and NK Cell-Mediated Suppression of Poorly Immunogenic Melanoma Metastases
Christopher J. Chan et al.
JOURNAL OF IMMUNOLOGY (2010)
HLA-E and HLA-G Expression in Classical HLA Class I-Negative Tumors Is of Prognostic Value for Clinical Outcome of Early Breast Cancer Patients
Esther M. de Kruijf et al.
JOURNAL OF IMMUNOLOGY (2010)
Invariant NKT Cells Preferentially Modulate the Function of CD8α+ Dendritic Cell Subset in Inducing Type 1 Immunity against Infection
Antony George Joyee et al.
JOURNAL OF IMMUNOLOGY (2010)
IL-2-driven Regulation of NK Cell Receptors With Regard to the Distribution of CD16+ and CD16- Subpopulations and In Vivo Influence After Haploidentical NK Cell Infusion
Sabine Huenecke et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses
Silke Paust et al.
NATURE IMMUNOLOGY (2010)
Interaction of C-type lectin-like receptors NKp65 and KACL facilitates dedicated immune recognition of human keratinocytes
Jessica Spreu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Natural Killer Cells in Allogeneic Transplantation: Effect on Engraftment, Graft- versus-Tumor, and Graft-versus-Host Responses
Saar Gill et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Activin-A attenuates several human natural killer cell functions
Neil C. Robson et al.
BLOOD (2009)
Replicative potential of human natural killer cells
Hiroyuki Fujisaki et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Re-organization of mitochondria at the NK cell immune synapse
Edgar Abarca-Rojano et al.
IMMUNOLOGY LETTERS (2009)
IL-12-Dependent Inducible Expression of the CD94/NKG2A Inhibitory Receptor Regulates CD94/NKG2C+ NK Cell Function
Andrea Saez-Borderias et al.
JOURNAL OF IMMUNOLOGY (2009)
Adaptive immune features of natural killer cells
Joseph C. Sun et al.
NATURE (2009)
Influence of the transcription factor ROR gamma t on the development of NKp46(+) cell populations in gut and skin
Carmelo Luci et al.
NATURE IMMUNOLOGY (2009)
Both Conventional and Interferon Killer Dendritic Cells Have Antigen-Presenting Capacity during Influenza Virus Infection
Corine H. GeurtsvanKessel et al.
PLOS ONE (2009)
Sustained NKG2D engagement induces cross-tolerance of multiple distinct NK cell activation pathways
Jerome D. Coudert et al.
BLOOD (2008)
Killer dendritic cells: IKDC and the others
Mathieu Bonmort et al.
CURRENT OPINION IN IMMUNOLOGY (2008)
Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1
Nicholas D. Huntington et al.
NATURE IMMUNOLOGY (2007)
Inhibitory effect of tumor cell-derived lactic acid on human T cells
Karin Fischer et al.
BLOOD (2007)
Dendritic cells prime natural killer cells by trans-presenting interleukin 15
Mathias Lucas et al.
IMMUNITY (2007)
In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infection
Yan Zhang et al.
IMMUNOLOGY (2007)
Developmental pathways that generate natural-killer-cell diversity in mice and humans
Nicholas D. Huntington et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Bone marrow versus thymic pathways of natural killer cell development
James P. Di Santo et al.
IMMUNOLOGICAL REVIEWS (2006)
A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127
Christian A. J. Vosshenrich et al.
NATURE IMMUNOLOGY (2006)
CD1d expression level in tumor cells is an important determinant for anti-tumor immunity by natural killer T cells
Kyoko Haraguchi et al.
LEUKEMIA & LYMPHOMA (2006)
Homing and function of human skin γδ T cells and NK cells:: Relevance for tumor surveillance
Lisa M. Ebert et al.
JOURNAL OF IMMUNOLOGY (2006)
Killer cell lectin-like receptor G1 binds three members of the classical cadherin family to inhibit NK cell cytotoxicity
M Ito et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
IL-21 enhances tumor rejection through a NKG2D-dependent mechanism
R Takaki et al.
JOURNAL OF IMMUNOLOGY (2005)
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer
JS Miller et al.
BLOOD (2005)
2B4 (CD244) is a non-MHC binding receptor with multiple functions on natural killer cells and CD8+ T cells
ME McNerney et al.
MOLECULAR IMMUNOLOGY (2005)
Role of trans-cellular IL-15 presentation in the activation of NK cell-mediated killing, which leads to enhanced tumor immunosurveillance
H Kobayashi et al.
BLOOD (2005)
Coordinate expression of cytokines and chemokines by NK cells during murine cytomegalovirus infection
BG Dorner et al.
JOURNAL OF IMMUNOLOGY (2004)
IL-21 induces the functional maturation of murine NK cells
J Brady et al.
JOURNAL OF IMMUNOLOGY (2004)
The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation
SI Fujii et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
IL-21 limits NK cell responses and promotes antigen-specific T cell activation: A mediator of the transition from innate to adaptive immunity
MT Kasaian et al.
IMMUNITY (2002)
CD66a interactions between human melanoma and NK cells: A novel class I MHC-independent inhibitory mechanism of cytotoxicity
G Markel et al.
JOURNAL OF IMMUNOLOGY (2002)
A small region of the natural killer cell receptor, Siglec-7, is responsible for its preferred binding to α2,8-disialyl and branched α2,6-sialyl residues -: A comparison with Siglec-9
T Yamaji et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
被撤回的出版物: The epithelial cellular adhesion molecule (Ep-CAM) is a ligand for the leukocyte-associated immunoglobulin-like receptor (LAIR) (Retracted Article. See vol 198, pg 1129, 2003)
L Meyaard et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population
K Imai et al.
LANCET (2000)